Advertisement

October 7, 2013

Terumo Launches Detachable Azur CX Peripheral Coil System

October 8, 2013—Terumo Interventional Systems (Somerset, NJ) announced the launch of its Azur CX peripheral coil system in the United States at the VIVA 2013: Vascular Interventional Advances conference, which is being held October 8 to 11 in Las Vegas, Nevada. The Azur CX system, which incorporates the company's hydrogel technology, is a peripheral embolization coil designed to provide cross-sectional coverage.

According to Terumo, Azur CX is an expansion of the company's Azur family of embolization coils for endovascular occlusion of peripheral vessels. The device features a coil construction with hydrogel on the inside for a soft, flexible design. The hydrogel technology creates a scaffold for neointimal growth formation and allows mechanical occlusion of the vessel with less reliance on thrombus for embolization. Azur CX creates a complex shape that enhances cross‐sectional coverage by filling the vessel and leaving no gap in the center. It can be deployed with minimal catheter manipulation.

The company noted that detachable coil technology and access devices allow physicians to treat a wider variety of patient conditions. Compared to traditional pushable embolic coils, detachable coils offer enhanced clinical benefits, including more precise positioning, which allows physicians to extend further into more tortuous anatomy, where distal embolization is a concern.

Frank R. Arko III, MD, of the Sanger Heart and Vascular Institute at Carolinas Medical Center in Charlotte, North Carolina, commented on the Azur CX device in Terumo's press release. Dr. Arko stated, “Placing embolic coils in high‐flow vessels is always a challenge because of the possibility the coil will move after placement. Maintaining control is critical. From the first loop, the Azur CX with hydrogel technology instills confidence, because it creates a stable anchor in the vessel. The coil has minimal preparation time, and with the Azur detachment controller, I can achieve precise placement.”

Advertisement


October 8, 2013

Biotronik Completes Iliac-Arm Enrollment in BIOFLEX-I Study

October 8, 2013

Biotronik Completes Iliac-Arm Enrollment in BIOFLEX-I Study


)